13F-HR: Merck & Co. 13F Holdings — September 30, 2026

Institutional Holdings Report (13F)


Merck & Co., Inc. reported 13 holdings worth $820.3M for the period ended September 30, 2026.

Summary

  • Merck & Co., Inc. reported 13 holdings worth $820.3M as of September 30, 2026.
  • MODERNA INC — $444.5M (54.18%), 2,308,190 SH.
  • PERSONALIS INC — $228.7M (27.87%), 14,044,943 SH.
  • KYMERA THERAPEUTICS INC — $86.3M (10.52%), 772,165 SH.
  • AKTIS ONCOLOGY INC — $18.6M (2.26%), 952,844 SH.
  • EIKON THERAPEUTICS INC — $13.4M (1.63%), 1,666,666 SH.

Top Holdings

Merck & Co., Inc. · 13 positions · $820.3M total · as of September 30, 2026
IssuerValue% Port.Shares
MODERNA INC$444.5M54.18%2,308,190
PERSONALIS INC$228.7M27.87%14,044,943
KYMERA THERAPEUTICS INC$86.3M10.52%772,165
AKTIS ONCOLOGY INC$18.6M2.26%952,844
EIKON THERAPEUTICS INC$13.4M1.63%1,666,666
ENTRADA THERAPEUTICS INC$11.0M1.35%1,739,768
ALECTOR INC$6.6M0.8%3,545,719
SUTRO BIOPHARMA INC$4.4M0.53%272,351
EVAXION AS$4.0M0.49%1,214,126
VIRIDIAN THERAPEUTICS INC$1.9M0.23%93,414

Keywords

13F, institutional holdings, Merck & Co., Inc., MODERNA INC, PERSONALIS INC, KYMERA THERAPEUTICS INC, AKTIS ONCOLOGY INC, EIKON THERAPEUTICS INC

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.